切换至 "中华医学电子期刊资源库"

中华关节外科杂志(电子版) ›› 2023, Vol. 17 ›› Issue (05) : 642 -647. doi: 10.3877/cma.j.issn.1674-134X.2023.05.007

临床论著

外周血细胞计数比值评估类风湿关节炎疗效的价值
高玲(), 于哲, 范然, 臧银善   
  1. 223800 宿迁市第一人民医院
  • 收稿日期:2023-04-18 出版日期:2023-10-01
  • 通信作者: 高玲

Evaluation value of peripheral blood cell count ratio for treatment efficacy of rheumatoid arthritis

Ling Gao(), Zhe Yu, Ran Fan, Yinshan Zang   

  1. Suqian First People's Hospital, Suqian 223800, China
  • Received:2023-04-18 Published:2023-10-01
  • Corresponding author: Ling Gao
引用本文:

高玲, 于哲, 范然, 臧银善. 外周血细胞计数比值评估类风湿关节炎疗效的价值[J]. 中华关节外科杂志(电子版), 2023, 17(05): 642-647.

Ling Gao, Zhe Yu, Ran Fan, Yinshan Zang. Evaluation value of peripheral blood cell count ratio for treatment efficacy of rheumatoid arthritis[J]. Chinese Journal of Joint Surgery(Electronic Edition), 2023, 17(05): 642-647.

目的

探讨外周血细胞计数比值在类风湿关节炎(RA)患者病情活动和疗效评估中的价值。

方法

回顾性分析2019年10月至2020年10月宿迁市第一人民医院收治的符合RA诊断标准且未接受过相关治疗116例RA患者的临床资料为观察组,排除心肝肾功能不全、合并血液或免疫系统疾病、恶性肿瘤者;另选择同期健康体检者96例为对照组。计算中性粒细胞/淋巴细胞比值(NLR)、血小板/淋巴细胞比值(PLR)、淋巴细胞/单核细胞比值(LMR)。观察组患者依据28个关节疾病活动评分(DAS28)分为缓解组和活动组;活动组患者再依据治疗后疗效分为有效组和无效组。多组间比较采用方差分析,两组间比较采用独立样本t检验。采用logistic回归分析临床资料确定RA病情活动的影响因素,并分析NLR、PLR、LMR与病情活动的相关性及治疗前后的变化差异。利用受试者工作特征曲线(ROC)及曲线下面积(AUC)评估NLR、PLR、LMR对RA病情活动及疗效的预测价值。

结果

根据DAS28评分缓解组为32例和活动组84例;活动组患者NLR、PLR水平均高于缓解组,LMR水平低于缓解组,差异均有统计学意义(t=3.957、6.336、3.696,均为P<0.001)。NLR、PLR、LMR对RA患者病情活动的曲线下面积(AUC)分别为0.835、0.810、0.812,敏感度分别为88.9%、69.1%、67.9%,特异度分别为74.3%、77.1%、85.7%。活动组患者依据疗效有效组有53例,无效组31例。有效组NLR、PLR值均低于无效组,LMR值均高于无效组,差异均有统计学意义(t=3.493、4.536、3.742,均为P<0.01)。NLR、PLR、LMR对RA患者治疗效果的AUC分别为0.777、0.749、0.783,敏感度分别为65.6%、59.4%、65.7%,特异度分别为85.7%、85.7%、77.5%。

结论

NLR、PLR、LMR是RA患者的病情活动的独立影响因素,对于评估病情活动及疗效具有较好价值,有效而简便,可作为临床中长期监测RA病情的参考指标。

Objective

To investigate the value of peripheral blood cell count ratio in evaluating disease activity and efficacy in patients with rheumatoid arthritis (RA).

Methods

The clinical data of 116 patients with RA who met the diagnostic criteria and did not receive relevant treatment in the First People's Hospital of Suqian City from October 2019 to October 2020 were retrospectively analyzed as the observation group, cardiac or hepatic-renal insuffiencies, hematological or immune system diseases, and malignant tumors were excluded; 96 healthy volunteers were selected as the control group at the same time. Neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR) and lymphocyte/monocyte ratio (LMR) were calculated. According to the 28 joint disease activity score (DAS28), patients were divided into the remission group and active group; then the patients in remission group were divided into effective group and invalid group according to the therapeutic effects after treatment. Variance analysis was used for comparison between multiple groups, and independent sample t test was used for comparison between two groups. Logistic regression was used to analyze clinical data to determine the influencing factors of RA disease activity, and the correlation between NLR, PLR, LMR and disease activity and the changes before and after treatment were analyzed. Receiver operating characteristic curve (ROC) and area under curve(AUC) of it was used to evaluate the predictive value of NLR, PLR and LMR in RA disease activity and outcomes.

Results

According DAS28, 32 patients were in remission group and 84 were in active group. The levels of NLR and PLR in active group were higher than those in remission group, while the levels of LMR were lower than those in remission group, with statistically significant differences (t=3.957, 6.336, 3.696, all P<0.001). The AUC of NLR, PLR and LMR for disease activity in RA patients were 0.835, 0.810 and 0.812, respectively. The sensitivities were 88.9%, 69.1% and 67.9%, and the specificities were 74.3%, 77.1% and 85.7%, respectively. According to therapeutic effects, 53 patients were in effective group and 31 were in invalid group. The NLR and PLR values of the effective group were lower than those of the ineffective group, and the LMR values were higher than those of the ineffective group, with statistical significance (t=3.493, 4.536, 3.742, all P<0.01). The AUC of NLR, PLR and LMR for RA patients was 0.777, 0.749 and 0.783 respectively; the sensitivity was 65.6%, 59.4% and 65.7%, and the specificity was 85.7%, 85.7% and 77.5%, respectively.

Conclusions

NLR, PLR and LMR are independent influencing factors of disease activity in patients with RA. They are effective and simple in evaluating disease activity and efficacy, and can be used as reference index for long-term clinical monitoring of RA disease.

表1 缓解组、活动组患者临床资料比较
Table 1 Comparison of clinical data of patients in remission group and active group
表2 缓解期组和活动期组NLR、PLR、LMR水平
Table 2 NLR, PLR, and LMR levels in the remission and active phase groups
图1 预测RA患者病情活动的各项指标的ROC(受试者工作特征曲线)注:参考线上方代表有诊断意义,参考线下方代表无诊断意义,越靠近左上角诊断价值越高
Figure 1 ROC of various indicators predicting disease activity in RA patientsNote: Above the reference line represents diagnostic significance, while below the reference line represents no diagnostic significance. The closer it is to the upper left corner, the higher the diagnostic value
表3 NLR、PLR、LMR对RA(类风湿)病情活动的预测价值
Table 3 Predictive value of NLR, PLR, and LMR for disease activity of RA
表4 不同疗效患者的NLR、PLR、LMR(±s)
Table 4 NLR, PLR, and LMR of patients with different therapeutic effects
图2 预测RA(类风湿)治疗效果各项指标的ROC (受试者工作特征曲线)注:参考线上方代表有诊断意义,参考线下方代表无诊断意义,越靠近左上角诊断价值越高
Figure 2 ROC of various indicators predicting treatment efficacy in RANote: Above the reference line represents diagnostic significance, while below the reference line represents no diagnostic significance. The closer it is to the upper left corner, the higher the diagnostic value
表5 不同疗效患者NLR、PLR、LMR对RA疗效的预测价值
Table 5 Prediction value of NLR, PLR, PLR of patients with different therapeutic effects
[1]
许冰馨,范凯健,王婷玉. 类风湿关节炎疼痛机制的研究进展[J]. 中南药学2020, 18(9): 1513-1516.
[2]
于芳,南方. 类风湿关节炎患者血清炎性因子与C反应蛋白和疾病活动度评分的相关性分析[J]. 国际免疫学杂志2018, 41(6): 644-647.
[3]
Hyndman IJ. Rheumatoid arthritis: past, present and future approaches to treating the disease[J]. Int J Rheum Dis, 2017, 20(4): 417-419.
[4]
宋瑶,吴福顺,韩勇,等. 中性粒细胞与淋巴细胞比值和淋巴细胞与单核细胞比值对类风湿关节炎合并间质性肺疾病的预测价值[J]. 延边大学医学学报2021, 44(2): 111-115.
[5]
井瑶瑶,杨洪亮,赵海丰,等. 外周血细胞计数及其比值对初诊伴非骨相关髓外病变的多发性骨髓瘤患者预后的评估价值[J]. 肿瘤防治研究2019, 46(5): 456-462.
[6]
Kumar LD, Karthik R, Gayathri N, et al. Advancement in contemporary diagnostic and therapeutic approaches for rheumatoid arthritis[J]. Biomed Pharmacother, 2016, 79: 52-61.
[7]
中华医学会风湿病学分会. 类风湿关节炎诊断及治疗指南[J]. 中华风湿病学杂志2010, 14(4): 265-270.
[8]
任艳红,董伟,柳华,等. 艾拉莫德联合甲氨蝶呤治疗类风湿性关节炎的临床观察[J]. 中国药房2017, 28(32): 4530-4533.
[9]
于晶晶,李慧敏,马瑞瑞,等. 类风湿关节炎合并骨质疏松的发病机制和治疗进展[J]. 中国现代医学杂志2020, 30(24): 51-56.
[10]
洪宏海,王征,夏勇. 长非编码RNA MT1JP调控p53抑制类风湿关节炎炎症反应作用及机制研究[J]. 风湿病与关节炎2017, 6(10): 5-9.
[11]
周婷婷,闫梦真,余婕,等. 类风湿性关节炎疼痛机制[J]. 生命的化学2020, 40(7): 1114-1120.
[12]
刘宏艳,包金环,魏华. 类风湿关节炎中Boolean缓解与其他缓解的关系研究[J]. 临床内科杂志2023, 40(3): 171-174.
[13]
Pisetsky DS. Advances in the treatment of rheumatoid arthritis: costs and challenges[J]. N C Med J, 2017, 78(5): 337-340.
[14]
叶丛,朱盈姿,余毅恺,等. 中性粒细胞/淋巴细胞比值在托珠单抗治疗类风湿关节炎疗效评估中的价值[J]. 临床内科杂志2017, 34(10): 669-672.
[15]
热依汉古丽·艾则孜,李瑾,胡安妮,等. 中性粒细胞/淋巴细胞比值、血小板/淋巴细胞比值与溃疡性结肠炎内镜活动度相关性[J]. 临床消化病杂志2021, 33(2): 102-106.
[16]
王凯,李鞠,李慧,等. 外周血细胞计数比值在类风湿关节炎病情活动和肺部受累评估中的价值[J]. 徐州医科大学学报2019, 39(1): 6-11.
[17]
李晓英,黄艳. 中性粒细胞/淋巴细胞比值、血小板/淋巴细胞比值与风湿性疾病关系的研究进展[J/CD]. 现代医学与健康研究电子杂志2023, 7(9): 138-141.
[18]
Giese MA, Hind LE, Huttenlocher A. Neutrophil plasticity in the tumor microenvironment[J]. Blood, 2019, 133(20): 2159-2167.
[19]
Cherfane CE, Gessel L, Cirillo D, et al. Monocytosis and a low lymphocyte to monocyte ratio are effective biomarkers of ulcerative colitis disease activity[J]. Inflamm Bowel Dis, 2015, 21(8): 1769-1775.
[20]
李龙杰,刘畅,张磊,等. 类风湿关节炎患者髌下脂肪垫及滑膜中炎性因子的水平[J]. 中国老年学杂志2020, 40(19): 4167-4170.
[21]
韩宇飞,高明利,刘东武. 类风湿性关节炎的发病机制研究进展综述[J]. 中国卫生标准管理2021, 12(01): 162-165.
[22]
Song X, Lin Q. Genomics, transcriptomics and proteomics to elucidate the pathogenesis of rheumatoid arthritis[J]. Rheumatol Int, 2017, 37(8): 1257-1265.
[1] 贺敬龙, 尚宏喜, 郝敏, 谢伟, 高明宏, 孙炜, 刘安庆. 重度类风湿关节炎患者行多关节置换术的临床手术疗效[J]. 中华关节外科杂志(电子版), 2023, 17(06): 860-864.
[2] 王宏宇. 固定与活动平台假体在全膝关节置换术中的应用价值[J]. 中华关节外科杂志(电子版), 2023, 17(06): 871-876.
[3] 许正文, 李振, 侯振扬, 苏长征, 朱彪. 富血小板血浆联合植骨治疗早期非创伤性股骨头坏死[J]. 中华关节外科杂志(电子版), 2023, 17(06): 773-779.
[4] 张曼, 李明庆, 李军苗. 当归四逆汤联合甲氨蝶呤治疗类风湿关节炎的疗效[J]. 中华关节外科杂志(电子版), 2023, 17(05): 648-652.
[5] 王泽勇, 覃健. 白细胞含量对富血小板血浆治疗运动系统损伤的影响[J]. 中华关节外科杂志(电子版), 2023, 17(05): 684-688.
[6] 王蓓蓓, 董启秀, 郗红燕, 于庆云, 张丽君, 式光. 早孕期孕妇药物流产失败的影响因素分析与构建相关预测模型及其对药物流产成功的预测价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 588-594.
[7] 陈絮, 詹玉茹, 王纯华. 孕妇ABO血型联合甲状腺功能检测对预测妊娠期糖尿病的临床价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 604-610.
[8] 王鹏, 肖厚安, 贾赤宇. 不同因素调控巨噬细胞极化在慢性难愈性创面中的研究进展[J]. 中华损伤与修复杂志(电子版), 2023, 18(05): 454-459.
[9] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[10] 甄子铂, 刘金虎. 基于列线图模型探究静脉全身麻醉腹腔镜胆囊切除术患者术后肠道功能紊乱的影响因素[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 61-65.
[11] 黄汇, 朱信强. 131I治疗45岁以下分化型甲状腺癌的疗效及影响因素[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 627-630.
[12] 张海涛, 康婵娟, 翟静洁. 胰管支架置入治疗急性胆源性胰腺炎效果观察[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 654-657.
[13] 陈垚, 徐伯群, 高志慧. 改良式中间上入路根治术治疗甲状腺癌的有效性安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 619-622.
[14] 黎熊, 曹永宽. 不同远切缘距离的ISR在局部进展期直肠癌新辅助治疗后的临床研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(04): 443-446.
[15] 王峰杰, 王礼光, 廖珊, 刘颖, 符荣党, 陈焕伟. 腹腔镜右半肝切除术治疗肝癌的安全性与疗效[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 517-522.
阅读次数
全文


摘要